G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 102 filers reported holding G1 THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 1.08 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $1,047,000 | -63.0% | 47,708 | -59.5% | 1.05% | -54.2% |
| Q1 2021 | $2,832,000 | +33.7% | 117,708 | 0.0% | 2.30% | +42.2% |
| Q4 2020 | $2,118,000 | -19.8% | 117,708 | -48.5% | 1.61% | -22.6% |
| Q3 2020 | $2,640,000 | -70.9% | 228,597 | -38.9% | 2.08% | -67.2% |
| Q2 2020 | $9,070,000 | +132.9% | 373,876 | -1.1% | 6.35% | +65.6% |
| Q1 2020 | $3,895,000 | -64.4% | 378,145 | -8.8% | 3.83% | -47.8% |
| Q4 2019 | $10,953,000 | – | 414,408 | – | 7.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 650,000 | $3,529,500 | 0.92% |
| CHI Advisors LLC | 333,945 | $1,813,321 | 0.48% |
| PVG ASSET MANAGEMENT CORP | 15,585 | $84,626 | 0.37% |
| Rhenman & Partners Asset Management AB | 370,000 | $2,009,100 | 0.21% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 184,000 | $999,120 | 0.18% |
| Birchview Capital, LP | 40,000 | $217 | 0.15% |
| XTX Topco Ltd | 102,282 | $555,391 | 0.12% |
| Tekla Capital Management LLC | 423,869 | $2,301,609 | 0.09% |
| Woodline Partners LP | 1,028,967 | $5,587,291 | 0.08% |
| Curi Wealth Management, LLC | 81,009 | $439,879 | 0.06% |